The global cardiac marker market is anticipated to grow at a considerable CAGR of 8.9% during the forecast period (2022-2028). Major market driver for the cardiac marker is pharmaceutical companies are providing funds for the development of novel biomarkers. Market players are working as a joint venture for better advancement in cardiovascular disease and its treatment. Pharmaceutical […]
